These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36091946)

  • 1. Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer.
    Li TH; Wang YY; Zhao BB; Qin C; Li ZR; Wang WB
    Heliyon; 2022 Sep; 8(9):e10416. PubMed ID: 36091946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
    Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
    Front Oncol; 2021; 11():665192. PubMed ID: 34123827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
    Wang Y; Kong Y; Yang Q; Zhong C; Zhou D
    Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer.
    Liu GH; Tan XY; Xu ZY; Li JX; Zhong GH; Zhai JW; Li MY
    Sci Rep; 2024 Jun; 14(1):13834. PubMed ID: 38879709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer.
    Ding C; Yu Z; Li X; Zhu J; Dai M; He Q
    Oncol Lett; 2023 Feb; 25(2):77. PubMed ID: 36742365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP12 is a prognostic biomarker and correlated with immune infiltrates in epithelial ovarian cancer.
    Ma R; Tang Z; Wang J
    J Gene Med; 2024 Jan; 26(1):e3585. PubMed ID: 37926491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses.
    Li TH; Qin XH; Wang LQ; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
    Heliyon; 2023 Oct; 9(10):e20464. PubMed ID: 37842592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC.
    Sun Y; Zhou Q; Sun J; Bi W; Li R; Wu X; Li N; Song L; Yang F; Yu Y
    Front Genet; 2022; 13():892727. PubMed ID: 36081993
    [No Abstract]   [Full Text] [Related]  

  • 13. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.
    Tan J; Chen F; Ouyang B; Li X; Zhang W; Gao X
    Front Oncol; 2022; 12():865756. PubMed ID: 36185189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
    Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
    J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration.
    Li T; Wang L; Yu N; Zeng A; Huang J; Long X
    Front Oncol; 2022; 12():1055308. PubMed ID: 36713580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer.
    Jiao M; Zhang F; Teng W; Zhou C
    Int J Gen Med; 2022; 15():3003-3030. PubMed ID: 35313552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data.
    Li D; Deng W; Huang G; Xiao X
    Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
    Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
    J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.